Sevil Yaşar

5.9k total citations
120 papers, 4.3k citations indexed

About

Sevil Yaşar is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Sevil Yaşar has authored 120 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cellular and Molecular Neuroscience, 33 papers in Psychiatry and Mental health and 24 papers in Pharmacology. Recurrent topics in Sevil Yaşar's work include Neurotransmitter Receptor Influence on Behavior (37 papers), Dementia and Cognitive Impairment Research (26 papers) and Cannabis and Cannabinoid Research (20 papers). Sevil Yaşar is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (37 papers), Dementia and Cognitive Impairment Research (26 papers) and Cannabis and Cannabinoid Research (20 papers). Sevil Yaşar collaborates with scholars based in United States, Italy and Hungary. Sevil Yaşar's co-authors include Steven R. Goldberg, Zuzana Justinová, Leigh V. Panlilio, Marcello Solinas, Michelle C. Carlson, Daniele Piomelli, Godfrey H. Redhi, Gianluigi Tanda, Jeff D. Williamson and Marco Pistis and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and NeuroImage.

In The Last Decade

Sevil Yaşar

117 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sevil Yaşar United States 38 1.7k 1.5k 903 811 600 120 4.3k
Luca Steardo Italy 42 1.8k 1.0× 2.0k 1.3× 1.3k 1.5× 993 1.2× 336 0.6× 137 5.8k
Nobuaki Egashira Japan 42 1.5k 0.9× 1.5k 1.0× 1.3k 1.4× 970 1.2× 264 0.4× 215 6.1k
Anders Fink‐Jensen Denmark 43 2.2k 1.3× 732 0.5× 1.9k 2.1× 803 1.0× 1.1k 1.9× 170 5.3k
Alasdair M. Barr Canada 48 2.6k 1.5× 765 0.5× 1.5k 1.7× 1.1k 1.3× 2.0k 3.3× 222 7.5k
Nela Pivac Croatia 39 1.1k 0.6× 579 0.4× 1.0k 1.1× 855 1.1× 985 1.6× 208 4.7k
Chi‐Un Pae South Korea 42 821 0.5× 1.8k 1.2× 987 1.1× 737 0.9× 2.4k 3.9× 310 6.9k
Neal R. Cutler United States 40 833 0.5× 1.5k 1.0× 831 0.9× 1.1k 1.3× 1.8k 3.0× 164 5.8k
Pamela White United Kingdom 18 894 0.5× 760 0.5× 808 0.9× 764 0.9× 215 0.4× 37 2.6k
Taro Kishi Japan 42 1.1k 0.6× 990 0.7× 883 1.0× 724 0.9× 1.9k 3.2× 233 5.5k
Gislaine Z. Réus Brazil 47 1.8k 1.1× 1.4k 1.0× 1.4k 1.6× 911 1.1× 1.1k 1.9× 167 7.3k

Countries citing papers authored by Sevil Yaşar

Since Specialization
Citations

This map shows the geographic impact of Sevil Yaşar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sevil Yaşar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sevil Yaşar more than expected).

Fields of papers citing papers by Sevil Yaşar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sevil Yaşar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sevil Yaşar. The network helps show where Sevil Yaşar may publish in the future.

Co-authorship network of co-authors of Sevil Yaşar

This figure shows the co-authorship network connecting the top 25 collaborators of Sevil Yaşar. A scholar is included among the top collaborators of Sevil Yaşar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sevil Yaşar. Sevil Yaşar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nieman, Carrie L., Emmanuel E. Garcia Morales, Alison Huang, et al.. (2024). Prevalence of Hearing Loss and Hearing Aid Use Among Persons Living With Dementia in the US. JAMA Network Open. 7(10). e2440400–e2440400. 3 indexed citations
2.
Shi, Wen, Doris Lin, Sevil Yaşar, et al.. (2024). Brain Frontal-Lobe Misery Perfusion in COVID-19 ICU Survivors: An MRI Pilot Study. Brain Sciences. 14(1). 94–94. 2 indexed citations
3.
Rhodius‐Meester, Hanneke, et al.. (2023). Cardiovascular Risk Management in Persons with Dementia. Journal of Alzheimer s Disease. 93(3). 879–889. 3 indexed citations
4.
Adams, Roy J., Esther S. Oh, Sevil Yaşar, Constantine G. Lyketsos, & Jennifer S. Mammen. (2023). Endogenous and Exogenous Thyrotoxicosis and Risk of Incident Cognitive Disorders in Older Adults. JAMA Internal Medicine. 183(12). 1324–1324. 13 indexed citations
5.
Giannini, Giulia, et al.. (2023). INPH and parkinsonism: A positive shunt response with a negative tap test. Frontiers in Neurology. 14. 1150258–1150258. 6 indexed citations
6.
Espeland, Mark A., Wendy L. Bennett, Sevil Yaşar, et al.. (2022). Associations between cognitive function and endogenous levels of estradiol and testosterone in adults with type 2 diabetes. Journal of Diabetes and its Complications. 36(9). 108268–108268. 2 indexed citations
7.
Gulyani, Seema, et al.. (2021). Evaluation of the effect comorbid Parkinson syndrome on normal pressure hydrocephalus assessment. Clinical Neurology and Neurosurgery. 207. 106810–106810. 7 indexed citations
8.
Carmichael, Owen, Kathleen M. Hayden, Christina E. Hugenschmidt, et al.. (2021). Does the impact of intensive lifestyle intervention on cognitive function vary depending baseline level of frailty? An ancillary study to the Action for Health in Diabetes (Look AHEAD) Trial. Journal of Diabetes and its Complications. 35(5). 107909–107909. 2 indexed citations
9.
Johnson, Emily L., Gregory L. Krauss, Keenan A. Walker, et al.. (2020). Late‐onset epilepsy and 25‐year cognitive change: The Atherosclerosis Risk in Communities (ARIC) study. Epilepsia. 61(8). 1764–1773. 17 indexed citations
10.
Johnson, Emily L., Gregory L. Krauss, Anna Kucharska‐Newton, et al.. (2020). Dementia in late-onset epilepsy. Neurology. 95(24). e3248–e3256. 60 indexed citations
11.
Nordheim, Johanna, Sevil Yaşar, Ralf Suhr, et al.. (2019). Psychosocial Intervention in Couples Coping with Dementia Led by a Psychotherapist and a Social Worker: The DYADEM Trial. Journal of Alzheimer s Disease. 68(2). 745–755. 15 indexed citations
12.
Espeland, Mark A., Owen Carmichael, Sevil Yaşar, et al.. (2018). Sex‐related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes. Alzheimer s & Dementia. 14(9). 1184–1192. 29 indexed citations
13.
Yaşar, Sevil, Ignacio Jusué-Torres, Mira Patel, et al.. (2017). Alzheimer’s disease pathology and shunt surgery outcome in normal pressure hydrocephalus. PLoS ONE. 12(8). e0182288–e0182288. 30 indexed citations
14.
Peters, Ruth, Mattan Schuchman, Jean Peters, Michelle C. Carlson, & Sevil Yaşar. (2016). Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies. Current Hypertension Reports. 18(8). 66–66. 21 indexed citations
15.
Mahinrad, Simin, Anton J.M. de Craen, Sevil Yaşar, Diana van Heemst, & Behnam Sabayan. (2016). Natriuretic peptides in the central nervous system: Novel targets for cognitive impairment. Neuroscience & Biobehavioral Reviews. 68. 148–156. 22 indexed citations
16.
Brinkley, Tina E., James Lovato, Alice M. Arnold, et al.. (2010). Effect of Ginkgo biloba on Blood Pressure and Incidence of Hypertension in Elderly Men and Women. American Journal of Hypertension. 23(5). 528–533. 40 indexed citations
17.
Solinas, Marcello, Gianluigi Tanda, Zuzana Justinová, et al.. (2007). The Endogenous Cannabinoid Anandamide Produces δ-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport. Journal of Pharmacology and Experimental Therapeutics. 321(1). 370–380. 84 indexed citations
18.
Yaşar, Sevil, María M. Corrada, Ron Brookmeyer, & Claudia H. Kawas. (2004). Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging. Neurobiology of Aging. 26(2). 157–163. 87 indexed citations
19.
Goldberg, Steven R., Sevil Yaşar, Jack Bergman, & Moussa B. H. Youdim. (1994). Introduction: Examination of clinical and preclinical pharmacologic data relating to abuse liability of l-deprenyl (selegiline)*. Clinical Pharmacology & Therapeutics. 56(6 Pt 2). 721–724. 4 indexed citations
20.
Yaşar, Sevil, Charles W. Schindler, Eric B. Thorndike, Istvan Szelenyi, & S.R. Goldberg. (1993). Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.. Journal of Pharmacology and Experimental Therapeutics. 265(1). 1–6. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026